Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 17 Sept 2026 for Upstream Bio, Inc., €4,060. Read the official filing
Filing timeline
BuySaleMichael Gray
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Gray: trading record in brief
Michael Gray is a declared insider at 2 companies (finance chief); the most frequent names are Enliven Therapeutics, Inc. and Upstream Bio, Inc. The record holds 6 filings, for trades running from 28 January 2022 to 16 September 2026.
On the market, this insider has only sold: 4 sales, €67k in total. Outside the open market, there are 2 share grants. In 2026 alone, the filings show no purchases and 2 sales.
On 17 September 2026 came the latest disclosure, an open-market sale for €4,060 in Upstream Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Gray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
853 shares@ US$5.49Common StockSEC:0001193125-26-394322:0
852 shares@ US$9.29100.0% of flowCommon StockSEC:0001193125-26-111138:0
30,500 shares0Common StockSEC:0001193125-26-004758:0
9,856 shares@ US$4.6776.9% of flowCommon StockSEC:0001209191-23-012016:0
3,596 shares@ US$3.9223.1% of flowCommon StockSEC:0001209191-23-005996:0
39,350 shares0Common StockSEC:0001209191-22-005926:0
6 of 6 declarations
